// App-Quantinova.ai

M1080 2016 AHA : Renin-Angiotensin Axis in Hematopoietic Stem/Progenitor Cells Predicts Vascular Dysfunction and Diabetic Retinopathy

Researchers

Presenter

  • Rehae C. Miller

Principal Investigators

  • Leni Moldovan

  • Ruchi J. Vyas

  • Patricia Parsons-Wingerter

  • Gavin Y. Oudit

  • Alexander G. Obukhov

  • Maria B. Grant

  • Eleni Beli

  • Tatiana Salazar

  • Sergio Li Calzi

  • Sugata Hazra

  • Jude Al-Sabah

  • Marya Meroueh

  • Kakarla V. Chalam

  • Sneha Raghunandan

Medical Centers

  • University of Utah, Salt Lake City, UT

  • NASA Ames Research Center,Moffett Field, CA

  • Mazankowski Alberta Heart Institute, Edmonton, AB, Canada

  • Univ of Florida, Jacksonville, FL

  • IN Univ Sch of Med, Indianapolis, IN

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetic retinopathy

  • Diabetes

Biomarkers

  • Cluster of Differentiation 34

  • Stromal cell-derived factor 1

Drug/Treatment

  • Fluorescein sodium

  • Angiotensin II

  • CXCL12

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim